National Emerging Infectious Diseases Laboratories Operations

国家新发传染病实验室运营

基本信息

批准号：
7123535
负责人：
Mark S Klempner
金额：
$ 71.41万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-07-01 至 2011-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7123535
关键词：
biomedical facility bioterrorism /chemical warfare cooperative study emerging infectious disease

biomedical facility bioterrorism /chemical warfare cooperative study emerging infectious disease

项目摘要

Under the terms of Grant Award UC6 AI58618 to construct a National Biocontainment Laboratory at Boston University we will build a safe, secure facility which incorporates all of the components necessary to support cutting edge basic, translational and clinical research on emerging infectious diseases including category A, B and C agents and which is integrated into the vibrant biomedical research and emergency preparedness environments of Boston University Medical Campus, the City of Boston, the region and the nation. We will also put into place comprehensive research, development and training programs which include all the necessary components to achieve the objectives of the NIAID's Strategic Plan for Biodefense Research emphasizing research and the development of diagnostic, preventative and therapeutic products to protect the population of the United States and the world against these agents. The National Biocontainment Laboratory (NBL) at Boston University will be known as the National Emerging Infectious Diseases Laboratories (NEIDL) Institute. The NEIDL Institute will be owned, operated and managed by a consortium of Boston University (BU) and Boston Medical Center (BMC). The NEIDL will be housed at the Boston University Medical Campus (see locus plan). Program activities may also be based at the Charles River Campus of Boston University and at offsite locations as appropriate.

根据授予奖项的条款UC6 AI58618在波士顿建造国家生物培养实验室我们将建立一个安全，安全的设施，该设施结合了支持的所有组件最先进的基本，转化和临床研究，包括A类，包括A类， B和C代理，并将其整合到充满活力的生物医学研究和应急准备中波士顿大学医学校园的环境，波士顿市，该地区和国家。我们将还将综合研究，开发和培训计划置于包括所有必要的组成部分，以实现NIAID的生物形式研究战略计划的目标强调研究和开发诊断，预防和治疗产品以保护美国和世界对这些代理商的人口。波士顿大学的国家生物疗养实验室（NBL）将被称为国家新兴传染病实验室（NEIDL）研究所。 Neidl Institute将由，运营和由波士顿大学（BU）和波士顿医疗中心（BMC）的联盟管理。 neidl将是位于波士顿大学医学校园（请参阅基因座计划）。计划活动也可能基于波士顿大学的查尔斯河校园和在异地地点适当的地方。